MO

Molina Healthcare, Inc.

MOHHealthcareNASDAQ

Healthcare Plans

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$45.43B
+11.7% YoY
Net Income
$472.0M
-60.0% YoY
Free Cash Flow
$700.2M

Scan Results

Daily timeframe
DateIndicatorDetails
Aug 18 MACD Positive CrossoverHistogram +1.3178, positive momentum
Aug 17 MACD Positive CrossoverHistogram +1.4095, positive momentum
About Molina Healthcare, Inc.

Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. With a market capitalization of $10.48B, it sits in large-cap territory. It operates through Medicaid, Medicare, Marketplace, and Other segments.

Where MOH stands vs its 150-day and 200-day moving averages

As of the August 18, 2026 close, MOH finished 13.23% above its 150-day moving average ($179.34) and 16.98% above its 200-day moving average ($173.58). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is MOH overbought or oversold?

At the August 18, 2026 close, MOH's RSI(14) was 52.4, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$10.48B
P/E (TTM)1255.00
Fwd P/E20.62
EPS$0.16
Beta0.76
52W Change+14.4%
ROE-0.2%
Analysis

Molina Healthcare, Inc. holds $8.92B in cash against $3.95B in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. The company generates $700.2M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at -0.2%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 1.2% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $31.97B (2022) to $45.43B (2025), reflecting a 42% increase over the period.

The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. The elevated P/E ratio means the stock is priced for significant future growth. If earnings disappoint, the price correction could be sharp. No single metric tells the full story. Reviewing MOH's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms